Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
01/2015
01/06/2015US8926989 Compositions and methods for screening for Lyme disease
01/06/2015US8926988 Mutant proteins of the F protein of PIV-5 and PIV-2
01/06/2015US8926987 Replication-competent adenoviral vectors
01/06/2015US8926986 Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax
01/06/2015US8926985 Vaccine
01/06/2015US8926983 Method for improving memory in AD patients
01/06/2015US8926982 Reagents and methods for detecting influenza virus proteins
01/06/2015US8926981 Methods of using chimeric receptors to identify autoimmune disease
01/06/2015US8926980 Compositions against bacterial toxins
01/06/2015US8926979 Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies
01/06/2015US8926977 Antibodies to the E1 extracellular loop of ion channels
01/06/2015US8926976 Modulators
01/06/2015US8926975 Method of treating ankylosing spondylitis
01/06/2015US8926974 Methods of treating a tauopathy
01/06/2015US8926973 Reducing the immunogenicity of fusion proteins
01/06/2015US8926971 Humanized anti-CCR2 antibodies and methods of use therefor
01/06/2015US8926970 Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis
01/06/2015US8926969 Anti-CD38 antibodies
01/06/2015US8926966 Cloned glutamic acid decarboxylase
01/06/2015US8926961 HPV E6 protein T cell epitopes and uses thereof
01/06/2015US8926957 Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
01/06/2015US8926956 Antibody recognizing human leukemia inhibitory factor (LIF)
01/06/2015US8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans
01/06/2015CA2630771C Protein constructs designed for targeting and lysis of cells
01/06/2015CA2607697C Treating and evaluating inflammatory disorders
01/06/2015CA2585196C Anti-glypican 3 antibody having modified sugar chain
01/06/2015CA2552553C Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer
01/06/2015CA2541671C Bispecific antibody substituting for functional proteins
01/06/2015CA2507080C Humanized antibodies against monocyte chemotactic proteins
01/06/2015CA2477195C Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
01/06/2015CA2421998C Vaccine against streptococcus pneumoniae
01/06/2015CA2367357C Method
01/01/2015US20150005477 Compositions and methods for conjugating activatable antibodies
01/01/2015US20150004700 Rationally designed antibodies
01/01/2015US20150004218 Compositions and methods for immune tolerance induction
01/01/2015US20150004194 Facilitator-dna combination vaccine
01/01/2015US20150004193 Novel dna-origami nanovaccines
01/01/2015US20150004191 Liquid Vaccines For Multiple Meningococcal Serogroups
01/01/2015US20150004190 Vaccine compositions for hiv prevention and treatment
01/01/2015US20150004189 Epitopes from allergen proteins and methods and uses for immune response modulation
01/01/2015US20150004188 Compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
01/01/2015US20150004187 Method for prevention of colectomy
01/01/2015US20150004186 Modulation of T Cell Signaling Threshold and T Cell Sensitivity to Antigens
01/01/2015US20150004184 Elastin digest compositions and methods utilizing same
01/01/2015US20150004179 Combination Therapy
01/01/2015US20150004175 Compositions and Methods for Reducing CTL Exhaustion
01/01/2015US20150004171 Pharmaceutical composition for treatment and/or prevention of cancer
01/01/2015US20150004167 Dual Variable Domain Immunoglobulin and Uses Thereof
01/01/2015US20150004165 Secreted proteins
01/01/2015US20150004164 Use Of Antibody
01/01/2015US20150004163 Adjuvant combinations comprising an nkt activator, a cd40 agent, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity
01/01/2015US20150004162 Surrogate binding proteins
01/01/2015US20150004161 Fc Coupled Compositions and Methods of Their Use
01/01/2015US20150004156 Novel pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type ii
01/01/2015US20150004154 Regimen for suppressing organ rejection
01/01/2015US20150004136 Responsiveness to angiogenesis inhibitors
01/01/2015US20150004132 Compositions and methods for generating an immune response
01/01/2015US20150004130 Nutritional Composition for Improving the Mammalian Immune System
01/01/2015US20150004129 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
12/2014
12/31/2014CN104254542A 包含分泌-样免疫球蛋白的组合物 Contains secretion - like immunoglobulin composition
12/31/2014CN104254340A 通过靶向骨髓中异常血管系统上表达的EphA3来治疗血液增殖性疾病的方法 By targeting the bone marrow EphA3 the abnormal expression of the vascular system to the treatment of a proliferative disorder in a blood
12/31/2014CN104250649A 皮肤角化-少毛-白甲综合征新的致病基因及其编码蛋白质和应用 Skin keratinocytes - less hair - white syndrome A new disease genes and their encoded proteins and application
12/31/2014CN104250640A 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 Pseudorabies virus gene deletion strains, vaccine composition and preparation method and application
12/31/2014CN104250638A 猪繁殖与呼吸综合征病毒弱毒株、疫苗组合物及其制备方法和应用 Porcine reproductive and respiratory syndrome virus attenuated strain, the vaccine composition and preparation method and application
12/31/2014CN104250637A 一株禽流感h9n2亚型病毒株及其应用 H9n2 virus subtype strain of avian flu strains and its application
12/31/2014CN104250636A 一种猪圆环病毒的培养方法及其应用 Pig circovirus culture method and its application
12/31/2014CN104250623A 一株猪鼻支原体菌株、疫苗组合物及其制备方法和应用 A hyorhinis strain vaccine composition and preparation method and application
12/31/2014CN104250304A 一种融合蛋白及其编码的疫苗组合物与应用 And encoding a fusion protein vaccine composition and Applications
12/31/2014CN104250302A 抗pd-1抗体及其应用 Anti-pd-1 antibody and uses thereof
12/31/2014CN104250301A 工程化抗体恒定结构域分子 Engineered antibody constant domain molecules
12/31/2014CN104248762A 一种猪流行性腹泻疫苗组合物及其制备方法和应用 Pig epidemic diarrhea vaccine composition and preparation method and application
12/31/2014CN104248761A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application
12/31/2014CN104248760A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application
12/31/2014CN104248759A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application
12/31/2014CN104248758A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application
12/31/2014CN104248757A 猪伪狂犬病病毒疫苗组合物及其制备方法和应用 Pseudorabies virus vaccine composition and preparation method and application
12/31/2014CN104248756A 一种抗犬伪狂犬病药物组合物 An anti-dog pseudorabies pharmaceutical compositions
12/31/2014CN104248755A 一种副猪嗜血杆菌病疫苗组合物及其制备方法和应用 One kind parasuis disease vaccine composition and preparation method and application
12/31/2014CN104248754A 猪链球菌疫苗组合物及其制备方法和应用 Suis vaccine composition and preparation method and application
12/31/2014CN104248753A 一种疫苗组合物及其应用 A vaccine composition and its application
12/31/2014CN103505723B 狂犬疫苗冻干制剂的制备方法 Preparation lyophilized preparation of rabies vaccine
12/31/2014CN103173419B 抗趋化因子4单克隆抗体、杂交瘤细胞系及应用 4 monoclonal anti-chemokine antibodies, hybridoma cell line and application
12/31/2014CN103160519B 金黄色葡萄球菌肠毒素b免疫制剂及其制备方法和应用 Staphylococcus aureus enterotoxin b immunization and its preparation method and application
12/31/2014CN103087188B 免疫球蛋白级分及其方法 Immunoglobulin fractions and methods
12/31/2014CN102924598B 抗体 Antibody
12/31/2014CN102827813B 抗人cd133单克隆抗体及其制备和应用 Cd133 anti-human monoclonal antibody and its preparation and application
12/31/2014CN102443052B Hiv的调节或辅助蛋白的肽、组合物及它们的应用 Hiv adjustment or auxiliary protein peptides, compositions and their use
12/31/2014CN102245640B 抗-pd-l1抗体及它们用于增强t细胞功能的用途 Use anti -pd-l1 antibodies and they are used to enhance the t-cell function
12/31/2014CN102078606B 一种呼吸道合胞病毒体疫苗及其制备方法 Body of a respiratory syncytial virus vaccine and its preparation method
12/31/2014CN101970499B 用于肿瘤治疗的单克隆抗体 Monoclonal antibodies for tumor therapy
12/31/2014CN101287755B 结合于人类白细胞抗原(hla)ⅰ类或ⅱ类分子的肿瘤相关肽及相关的抗癌疫苗 Binding to human leukocyte antigen (hla) ⅰ ⅱ class or classes of tumor-associated peptide molecules and related anti-cancer vaccine
12/30/2014US8921537 Anti-VEGF antibodies
12/30/2014US8921536 HCV vaccines and methods for using the same
12/30/2014US8921535 Infectious clones of torque teno virus
12/30/2014US8921534 Enhancement of the immune response using CD36-binding domain
12/30/2014US8921529 Therapies for preventing or suppressing Clostridium difficile infection
12/30/2014US8921528 Bispecific fusion antibodies with enhanced serum half-life
12/30/2014US8921527 Antibody-containing solution formulations
12/30/2014US8921526 Mutated anti-TNFα antibodies and methods of their use
12/30/2014US8921523 Humanized anti-beta-amyloid antibodies
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 1823